Metabolite profile of benzoic acid biotransformation with hippuric acid as outcome. by Cindy Irwin (3373793)

“…Enzyme nomenclature (names accepted by the IUBMB): EC 1.4.1.2: glutamate dehydrogenase; EC 2.1.1.2: guanidinoacetate N-methyltransferase; EC 2.1.2.1: glycine hydroxymethyltransferase (alt.: serine hydroxymethyltransferase); EC 2.1.2.10: aminomethyltransferase (a glycine synthetase); EC 2.1.3.3: ornithine carbamoyltransferase; EC 2.1.4.1: glycine amidinotransferase; EC 2.3.1.1: amino-acid N-acetyltransferase; EC 2.3.1.71: glycine N-benzoyltransferase (a GLYAT); EC 2.7.3.2: creatine kinase; EC 3.5.3.1: arginase; EC 4.3.2.1: argininosuccinate lyase; EC 6.2.1.2: butyrate-CoA ligase (a medium-chain acyl-CoA ligase); EC 6.3.4.5: argininosuccinate synthase; EC 6.3.5.5: carbamoyl-phosphate synthase (glutamine-hydrolyzing)</p>…”

Nuclear proteome profiling in A549 cells after DOX and/or LMB treatment. by Chuanwen Lu (159114)

“…Nuclear proteins treated with LMB or vehicle control were labeled with Cy3 (green channel) and Cy5 (red channel), respectively. Nuclear proteins were separated based on isoelectric point (PI, horizontal axis) and molecular weight (MW, vertical axis). …”

Table_1_Profile of Immunoglobulin G N-Glycome in COVID-19 Patients: A Case-Control Study.docx by Haifeng Hou (622765)

“…COVID-19 patients have a decreased level of IgG fucosylation, which upregulates antibody-dependent cell cytotoxicity (ADCC) in acute immune responses. …”

Percentage of exhale flux penetrating through the mask fabric for different values of <i>c</i>_<i>k</i>; a–c and d–f decreasing porosity for outward and inward protection... by Akshay Anand (118579)

Image_2_SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope.TIF by Yue Liu (292931)

“…Further investigation discovered that SERINC5 increased the non-glycosylation of LHB, MHB, and SHB proteins of HBV and slightly decreased HBs proteins levels, which led to the decreased HBV secretion. …”

Image_3_SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope.TIF by Yue Liu (292931)

“…Further investigation discovered that SERINC5 increased the non-glycosylation of LHB, MHB, and SHB proteins of HBV and slightly decreased HBs proteins levels, which led to the decreased HBV secretion. …”

Table_1_SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope.PDF by Yue Liu (292931)

“…Further investigation discovered that SERINC5 increased the non-glycosylation of LHB, MHB, and SHB proteins of HBV and slightly decreased HBs proteins levels, which led to the decreased HBV secretion. …”

Image_1_SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope.TIF by Yue Liu (292931)

“…Further investigation discovered that SERINC5 increased the non-glycosylation of LHB, MHB, and SHB proteins of HBV and slightly decreased HBs proteins levels, which led to the decreased HBV secretion. …”

Image_1_SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope.TIF by Yue Liu (292931)

“…Further investigation discovered that SERINC5 increased the non-glycosylation of LHB, MHB, and SHB proteins of HBV and slightly decreased HBs proteins levels, which led to the decreased HBV secretion. …”

Table_1_SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope.PDF by Yue Liu (292931)

“…Further investigation discovered that SERINC5 increased the non-glycosylation of LHB, MHB, and SHB proteins of HBV and slightly decreased HBs proteins levels, which led to the decreased HBV secretion. …”

Image_3_SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope.TIF by Yue Liu (292931)

“…Further investigation discovered that SERINC5 increased the non-glycosylation of LHB, MHB, and SHB proteins of HBV and slightly decreased HBs proteins levels, which led to the decreased HBV secretion. …”

Image_2_SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope.TIF by Yue Liu (292931)

“…Further investigation discovered that SERINC5 increased the non-glycosylation of LHB, MHB, and SHB proteins of HBV and slightly decreased HBs proteins levels, which led to the decreased HBV secretion. …”

Animal test and gene expression analysis of HA-v vaccine treated rats. by Haruka Momose (596190)

“…Four rats were used for HA, and three rats were used for HA-v. (A) Changes in rat body weight were assessed as the percentage increase or decrease, and are indicated by the mean change ± S.D. …”

Locus deletion on chromosome 10 in the Lin5FU500.4 mutant. by Jean-François Ritt (488623)

“…<p>(<b>A</b>). Comparative genomic hybridization (CGH) experiments between Lin5FU500.4 and the WT strain. …”

ALKBH5 induces macrophage activation to promote renal fibrosis via Retnla by Long Zheng (694761)

“…Further studies showed that ALKBH5 deficiency reduced M2a macrophage polarization and the expression of TGF-β1, Arg1, and CD206 both <i>in vivo</i> and <i>in vitro</i>. …”

The changes in the total sialic acid level according to various concentration of deoxycholic acid (0 μM, 75 μM and 150 μM) added for HeLa (Graph A) and HuCCT1 (Graph B) cells. by Hyo Jeong Kim (7490237)

DN Rab5 (S34N) retards endocytosis of KCa2.3. by Yajuan Gao (309862)

“…</b> Expression of S34N Rab5 resulted in a significant decrease of KCa2.3 endocytosis, relative to WT Rab5 (<i>n</i> = 3; *P<0.05). …”

Image5_Enteroendocrine Cell Formation Is an Early Event in Pancreatic Tumorigenesis.TIF by Leah R. Caplan (12464541)

“…<p>Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a 5-year survival rate of only 11%, due, in part, to late diagnosis, making the need to understand early events in tumorigenesis critical. …”

Peak abundances for the N-glycans which had the obvious overall changes among control subjects, moderate and severe LCMM subjects. by Jie Chen (5892)

Alpha diversity in F2 samples with sulfite treatment at time 0. by Sally V. Irwin (4521733)